BRL-15,572

BRL-15,572
Clinical data
ATC code	none;
Identifiers
	IUPAC name 3-(4-(3-chlorophenyl)piperazin-1-yl)-1,1-diphenyl-2-propanol;
CAS Number	193611-72-2 ;
PubChem CID	3654103;
IUPHAR/BPS	10;
ChemSpider	2887678 ;
ChEMBL	ChEMBL534232 ;
CompTox Dashboard (EPA)	DTXSID4043983 ;
Chemical and physical data
Formula	C25H27ClN2O
Molar mass	406.95 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Clc2cccc(c2)N1CCN(CC1)CC(O)C(c3ccccc3)c4ccccc4;
	(what is this?) (verify)

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

BRL-15,572 is a drug which acts as a selective antagonist for the serotonin receptor subtype 5-HT_1D, with around 60x selectivity over other related receptors. The 5-HT_1D receptor has a very similar pharmacology to the closely related 5-HT_1B receptor, and most older ligands for these receptors bind to both subtypes with approximately equal affinity, so development of compounds such as BRL-15572 which are able to selectively block the 5-HT_1D subtype while leaving 5-HT_1B unaffected, have been a significant advance which has helped scientists in researching the function of these serotonin receptor subtypes.^[1]^[2] One function of the 5-HT_1D receptor this research has revealed is its role in modulating release of the neurotransmitter glutamate in the brain,^[3] as well as functions in regulation of cerebral blood pressure which are important in the pathogenesis of migraine headaches.^[4]

References

^ Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Göthert M, et al. (September 1997). "SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 356 (3): 312–20. doi:10.1007/pl00005056. PMID 9303567. S2CID 26760453.
^ Schlicker E, Fink K, Molderings GJ, Price GW, Duckworth M, Gaster L, et al. (September 1997). "Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 356 (3): 321–7. doi:10.1007/pl00005057. PMID 9303568. S2CID 12246022.
^ Marcoli M, Maura G, Munari C, Ruelle A, Raiteri M (February 1999). "Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions". British Journal of Pharmacology. 126 (3): 607–12. doi:10.1038/sj.bjp.0702336. PMC 1565844. PMID 10188970.
^ Goadsby PJ, Classey JD (2003). "Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input". Neuroscience. 122 (2): 491–8. doi:10.1016/s0306-4522(03)00570-0. PMID 14614913. S2CID 24825348.

[1] Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Göthert M, et al. (September 1997). "SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 356 (3): 312–20. doi:10.1007/pl00005056. PMID 9303567. S2CID 26760453.

[2] Schlicker E, Fink K, Molderings GJ, Price GW, Duckworth M, Gaster L, et al. (September 1997). "Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 356 (3): 321–7. doi:10.1007/pl00005057. PMID 9303568. S2CID 12246022.

[3] Marcoli M, Maura G, Munari C, Ruelle A, Raiteri M (February 1999). "Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions". British Journal of Pharmacology. 126 (3): 607–12. doi:10.1038/sj.bjp.0702336. PMC 1565844. PMID 10188970.

[4] Goadsby PJ, Classey JD (2003). "Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input". Neuroscience. 122 (2): 491–8. doi:10.1016/s0306-4522(03)00570-0. PMID 14614913. S2CID 24825348.

[1]

[2]

[3]

[4]